drug · small molecule
sufentanil citrate
Marketedupdated 6mo agoby $TLPH TALPHERA, INC.🔗 ChEMBL
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4Small molecule drug with a maximum clinical stage of Approval, with an approval for pain.
targets
Mu-type opioid receptor
all catalysts(30)
approval · 30
May 4, 1984
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Sep 10, 1984
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Aug 21, 1985
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Aug 21, 1985
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Mar 18, 1986
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Mar 18, 1986
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Jun 20, 1986
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Aug 6, 1986
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Nov 14, 1986
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Nov 14, 1986
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Apr 29, 1987
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Oct 5, 1990
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Nov 10, 1992
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Mar 19, 1993
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Mar 23, 1994
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Mar 23, 1994
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Mar 23, 1994
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Feb 22, 1995
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Jun 21, 1996
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Aug 12, 1997
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
May 1, 1998
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
May 26, 1998
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
May 25, 1999
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Aug 27, 2001
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Jun 4, 2007
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Mar 20, 2014
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Dec 16, 2016
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Oct 7, 2019
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Dec 15, 2023
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Dec 22, 2025
approval
SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approval
sufentanil citrate
→
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 5, 2027
50 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (21)
- Feb 2, 2038formulationUS 11672738
- Jul 29, 2031formulationUS 89455924.7y
- Oct 22, 2030method-of-use (U-1351)US 82025353.9y
- Oct 22, 2030method-of-use (U-1351)US 88657433.9y
- Mar 16, 2030formulationUS 108967513.3y
- Mar 16, 2030formulationUS 116766913.3y
- Mar 16, 2030formulationUS 120337333.3y
- Mar 16, 2030formulationUS 85741893.3y
- Jan 5, 2027formulationUS 1024522850d
- Jan 5, 2027formulationUS 1034276250d
- Jan 5, 2027formulationUS 1050718050d
- Jan 5, 2027formulationUS 822697850d
- Jan 5, 2027formulationUS 823190050d
- Jan 5, 2027formulationUS 825232850d
- Jan 5, 2027formulationUS 825232950d
- Jan 5, 2027formulationUS 853571450d
- Jan 5, 2027method-of-use (U-1351)US 877839350d
- Jan 5, 2027method-of-use (U-1351)US 877839450d
- Jan 5, 2027method-of-use (U-1351)US 886521150d
- Jan 5, 2027method-of-use (U-1351)US 932071050d
- Jan 5, 2027formulationUS 974412950d
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that